News blog

Oxford Pharmascience Group

  • BY: Andrew Hore |
  • POSTED: 26/11/2012 |

Oxford Pharmascience Group is raising £2m at 1.3p a share.

At 1.5p a share, Oxford Pharmascience is currently valued at £8.66m.

The cash will be used to finance the development of new products. It will also be used to finance expected cash outflows from losses. There was £639,000 in the bank at the end of June 2012. The first half cash outflow was £466,000.

Oxford Pharmascience has three main technologies: soft chew technology OXPchew, taste-masking platform OXPzero and controlled-release technology OXPtarget.

There will be clinical studies in early 2013 to demonstrate the bio equivalence of our OXPzero™ ibuprofen salt.

Download the latest AIM Journal from

© 2021 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds